Solana (NASDAQ:HSDT) Issues Quarterly Earnings Results

Solana (NASDAQ:HSDT) released its quarterly earnings results on Tuesday. The company reported ($32.89) EPS for the quarter, Zacks reports. Solana had a negative net margin of 7,215.25% and a negative return on equity of 699.93%.

Solana Stock Performance

Solana stock traded down $0.30 during midday trading on Tuesday, reaching $4.00. 2,069,130 shares of the stock were exchanged, compared to its average volume of 439,043. The company’s fifty day moving average is $11.24 and its 200-day moving average is $44.81. The firm has a market cap of $4.32 million, a PE ratio of 0.00 and a beta of 1.00. Solana has a 52 week low of $3.81 and a 52 week high of $1,200.00.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen lowered Solana from a “hold” rating to a “sell” rating in a research note on Saturday, September 20th. Weiss Ratings reissued a “sell (e+)” rating on shares of Solana in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Solana currently has an average rating of “Sell”.

About Solana

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.